|
FCF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.86030000187887E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.640800E-04 |
| Normal-vs-Stage2 |
5.58909999999191E-05 |
| Normal-vs-Stage3 |
3.79550002538309E-09 |
| Normal-vs-Stage4 |
1.13489999997718E-06 |
| Stage1-vs-Stage2 |
3.904400E-02 |
| Stage1-vs-Stage3 |
1.796680E-04 |
| Stage1-vs-Stage4 |
5.455700E-03 |
| Stage2-vs-Stage3 |
4.737000E-01 |
| Stage2-vs-Stage4 |
5.847000E-01 |
| Stage3-vs-Stage4 |
9.184400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.62280000337978E-08 |
| Normal-vs-AfricanAmerican |
4.008400E-04 |
| Normal-vs-Asian |
4.409200E-01 |
| Caucasian-vs-AfricanAmerican |
7.031600E-01 |
| Caucasian-vs-Asian |
3.691200E-01 |
| AfricanAmerican-vs-Asian |
3.199000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54949999497944E-08 |
| Normal-vs-Female |
5.82579999999222E-05 |
| Male-vs-Female |
1.561990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.519700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.60350000000853E-05 |
| Normal-vs-Age(61-80Yrs) |
8.11040001824637E-09 |
| Normal-vs-Age(81-100Yrs) |
1.960380E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.176800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.971200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.029000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.013790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.428580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.998000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.896800E-01 |
| Normal-vs-Grade 2 |
2.101100E-03 |
| Normal-vs-Grade 3 |
1.401599947215E-10 |
| Normal-vs-Grade 4 |
3.79329999966593E-07 |
| Grade 1-vs-Grade 2 |
6.017800E-02 |
| Grade 1-vs-Grade 3 |
9.557200E-04 |
| Grade 1-vs-Grade 4 |
2.738300E-03 |
| Grade 2-vs-Grade 3 |
4.18180000000268E-05 |
| Grade 2-vs-Grade 4 |
4.384700E-04 |
| Grade 3-vs-Grade 4 |
4.926000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.102600E-03 |
| Normal-vs-ccB subtype |
4.0291999958697E-08 |
| ccA subtype-vs-ccB subtype |
1.542630E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61414999999554E-05 |
| Normal-vs-N1 |
1.84560000004996E-06 |
| N0-vs-N1 |
6.148200E-02 |
|
|
